Guidelines for treatment of HIV infected adults in Europe
De-simplification for cost savings
321 HIV-infected Canadian patients on Triumeq® were offered to voluntarily switch to Tivicay® in combination with generic abacavir/lamivudine from January 2015 to January 2018. No incentives were provided.
EACS Guidelines
Magazine